TG
AGIO icon

TLP Group’s Agios Pharmaceuticals AGIO Stock Holding History

TLP Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed – – 57
2018
Q3 		$0 Buy
+1
New +$80 ﹤0.01% 400
2017
Q4 		– Sell
-1
Closed -$1K – 581
2017
Q3 		$1K Sell
1
-57
-98% -$3.42K ﹤0.01% 513
2017
Q2 		$3K Buy
+58
New +$2.96K ﹤0.01% 281

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

TLP Group's AGIO Position: Q4 2018 in Review

TLP Group sold out of Agios Pharmaceuticals (AGIO) in Q4 2018, closing a stake of 1 share.

TLP Group first reported a position in AGIO in Q2 2017 and held it in 3 quarters. The position peaked at $3K in Q2 2017. 196 funds tracked by Wall St. Rank hold AGIO as of Q4 2018.

  • TLP Group reported no remaining Agios Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 1 Agios Pharmaceuticals share in Q4 2018.
  • TLP Group first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 3 quarters.
  • TLP Group's Agios Pharmaceuticals position peaked at $3K in Q2 2017.
  • 196 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.